Eiger's Single-dose Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization or ER Visits by 50% in a Predominantly Vaccinated Population in Phase 3 TOGETHER Study

Category Primary study
Web pagePress release - PR Newswire - Mar 17, 2022, 08:00 ET
Year 2022

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
This article has no abstract
Epistemonikos ID: 98ba6a2f6797c5ff452755222d9909f85c5a528d
First added on: Apr 23, 2022